Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Cartilage Tissue Engineering Using Injectable Functionalized Demineralized Bone Matrix Scaffold With Glucosamine in Pva Carrier, Cultured in Microbioreactor Prior to Study in Rabbit Model Publisher Pubmed



Dadgar N1 ; Ghiaseddin A2, 3, 4 ; Irani S1 ; Rabbani S5 ; Tafti SHA5 ; Soufizomorrod M6 ; Soleimani M6, 7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran
  2. 2. Biomedical Engineering Division, Chemical Engineering Department, Tarbiat Modares University, Tehran, Iran
  3. 3. Department of Anatomical Sciences, Faculty of Medical Science, Tarbiat Modares University, Tehran, Iran
  4. 4. Department of Chemistry, Michigan State University, East Lansing, MI, United States
  5. 5. Research Center for Advanced Technologies in Cardiovascular Medicine, Cardiovascular diseases Research institute, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Department of Hematology and Cell Therapy, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
  7. 7. Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Source: Materials Science and Engineering C Published:2021


Abstract

Using 3D model of injectable scaffolds for cartilage tissue engineering is one of the challenges that should be addressed to avoid invasive surgery for treatment. For this purpose, chondrocytes on Demineralized Bone Matrix (DBM) scaffolds functionalized with glucosamine in 20% polyvinyl alcohol (PVA) as a carrier was applied to the micro-bioreactor in-vitro, then the study was continued on in-vivo stage. Scaffold biocompatibility tests were performed and the mechanical and physicochemical properties were studied showing the fact that DBM was functionalized by Glucosamine, scaffold degradation rate was 53% after 720 h and swelling ratio was 2.5 times after 16 h, injectable scaffold demonstrated better mechanical characteristics (P < 0.05) than other concentrations of PVA. Consequently, in-vitro tests, including live-dead imaging resulting in 99% viability after 14 days (P < 0.001), DAPI staining and scanning electron microscope imaging were performed to determine the number and viability of the cells on the scaffold, showing a cells proliferation property of this group compared with the control after 14 days (P < 0.0001), then relative gene expression was evaluated and protein expression was assessed. The overall chondrogenic gene expression improved (P < 0.05) compared to the control (2D culture). Subsequently, the scaffold were loaded with chondrocytes and injected into the cartilage lesion part After 24 weeks of surgery, MRI and immunocytochemistry were performed. Then all outputs proved that the scaffold plus cell group had a significantly higher topological score (P < 0.0001) than other groups compared to normal cartilage. Finally, studies have shown that transplantation of chondrocytes in DBM, polyvinyl alcohol and glucosamine scaffold through one surgical stage improves cartilage lesion and it can be considered as a breakthrough in tissue engineering. © 2020 Elsevier B.V.